Company Filing History:
Years Active: 2013-2016
Title: Klaus Graumann: Innovator in Biopharmaceutical Storage Solutions
Introduction
Klaus Graumann is a notable inventor based in Schwaz, Austria. He has made significant contributions to the field of biopharmaceuticals, particularly in the storage of recombinant proteins. With a total of 3 patents to his name, Graumann's work has the potential to enhance the stability and efficacy of important medical treatments.
Latest Patents
One of Klaus Graumann's latest patents focuses on the long-term storage of non-glycosylated recombinant human Granulocyte-Colony Stimulating Factor (G-CSF). This invention provides a method for stable long-term storage of G-CSF by cooling an aqueous acetate or glutamate buffered G-CSF composition containing sorbitol to a temperature of -15°C or below. The frozen composition is then stored in this state and later thawed to a temperature between 2°C and 8°C, ensuring that the G-CSF content remains at least 95% of the original composition. This innovative approach addresses critical challenges in the biopharmaceutical industry regarding the stability of therapeutic proteins.
Career Highlights
Klaus Graumann has built a successful career at Sandoz AG, a global leader in generic pharmaceuticals and biosimilars. His expertise in biopharmaceutical storage solutions has positioned him as a key figure in the development of effective storage methods for sensitive biological products. His contributions have not only advanced the field but have also improved patient access to essential medications.
Collaborations
Throughout his career, Klaus has collaborated with esteemed colleagues such as Helmut Lerch and Thomas Lauber. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their work in the biopharmaceutical sector.
Conclusion
Klaus Graumann's innovative approaches to the long-term storage of recombinant proteins exemplify the importance of advancements in biopharmaceuticals. His patents and career at Sandoz AG highlight his commitment to improving medical treatments and patient care.